YasminC.GosiengfiaoMD

Pediatric Hematology & Oncology • Chicago, IL

Assistant Professor in Pediatrics, Northwestern University Medical School

Join to view full profile

Dr. Gosiengfiao is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Gosiengfiao's full profile

Already have an account?

Office
2300 N Childrens Plz 30
Chicago, IL 60614
Phone+1 773-880-4074

Fax+1 312-227-9377

Education & Training

McGaw Medical Center of Northwestern UniversityFellowship, Pediatric Hematology/Oncology, 2001 - 2004
University of Illinois College of Medicine at ChicagoResidency, Pediatrics, 1997 - 2000
Ascension Illinois/Saint FrancisInternship, Internal Medicine, 1996 - 1997
University of the Philippines College of MedicineClass of 1995

Certifications & Licensure

IL State Medical License 2000 - 2026
FL State Medical License 2018 - 2024
NC State Medical License 2018 - 2023
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma Start of enrollment: 2001 Oct 18
Active, not recruiting
Phase 3
Study of Kidney Tumors in Younger Patients Start of enrollment: 2006 Feb 27
Recruiting
Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma Start of enrollment: 2000 Nov 06
Recruiting
Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer Start of enrollment: 2009 Sep 14
Active, not recruiting
Phase 3
Irinotecan Hydrochloride and Temozolomide With Temsirolimus or Dinutuximab in Treating Younger Patients With Refractory or Relapsed Neuroblastoma Start of enrollment: 2013 Feb 12
Completed
Phase 2
Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma Start of enrollment: 2014 Aug 08
Active, not recruiting
Phase 3
Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer Start of enrollment: 2009 Sep 01
Join now to see all

Publications & Presentations

PubMed

98 citations
Testicular tissue cryopreservation: 8 years of experience from a coordinated network of academic centers
Hanna Valli-Pulaski, Karen A. Peters, Kathrin Gassei, Sarah Steimer, Meena Sukhwani
Human Reproduction. 2019-06-04
6 citations
Proximal Hypospadias and a Novel WT1 Variant: When Should Genetic Testing Be Considered?
Elizabeth Dabrowski, Amy E. Armstrong, Elizabeth A. Leeth, Emilie K. Johnson, Earl Y. Cheng
Pediatrics. 2018-04-01
10 citations
Acute Menopausal Symptoms in Young Cancer Survivors Immediately following Chemotherapy.
Katherine E. Cameron, Martha B. Kole, Mary D. Sammel, Jill P. Ginsberg, Yasmin Gosiengfiao
Oncology. 2018-03-01

Professional Memberships

American Society of Clinical Oncology - ASCO
Member
American Society of Hematology - ASH
Member